Rachid Tobal

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Organ damage in systemic sclerosis: linking immune activation, vasculopathy, and fibrosis to precision treatment.

Organ damage in systemic sclerosis: linking immune activation, vasculopathy, and fibrosis to precision treatment.

Journal: Expert review of clinical immunology

Published: May 21, 2026

Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange.

Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange.

Journal: Journal of translational autoimmunity

Published: December 27, 2025

Prostaglandin E1 restores endothelial progenitor cell function in systemic sclerosis.

Prostaglandin E1 restores endothelial progenitor cell function in systemic sclerosis.

Journal: Rheumatology (Oxford, England)

Published: December 01, 2024

Etiology and Outcomes of Kidney-Limited and Systemic Thrombotic Microangiopathy.

Etiology and Outcomes of Kidney-Limited and Systemic Thrombotic Microangiopathy.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: September 19, 2024

High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension.

High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension.

Journal: Diagnostics (Basel, Switzerland)

Published: May 01, 2024

Dephosphorylated uncarboxylated Matrix-Gla-Protein as candidate biomarker for immune-mediated vascular remodeling and prognosis in pulmonary hypertension.

Dephosphorylated uncarboxylated Matrix-Gla-Protein as candidate biomarker for immune-mediated vascular remodeling and prognosis in pulmonary hypertension.

Journal: Scientific reports

Published: April 26, 2024

Breathomics to monitor interstitial lung disease associated with systemic sclerosis.

Breathomics to monitor interstitial lung disease associated with systemic sclerosis.

Journal: ERJ open research

Published: February 27, 2024

Association of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosis.

Association of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosis.

Journal: The European respiratory journal

Published: February 08, 2024

Plasma Dephosphorylated-Uncarboxylated Matrix Gla-Protein in Systemic Sclerosis Patients: Biomarker Potential for Vascular Calcification and Inflammation.

Plasma Dephosphorylated-Uncarboxylated Matrix Gla-Protein in Systemic Sclerosis Patients: Biomarker Potential for Vascular Calcification and Inflammation.

Journal: Diagnostics (Basel, Switzerland)

Published: October 12, 2023

Favorable long term effects of intensified immunosuppression combined with therapeutic plasma exchange in patients with early-onset progressive systemic sclerosis-related interstitial lung disease.

Favorable long term effects of intensified immunosuppression combined with therapeutic plasma exchange in patients with early-onset progressive systemic sclerosis-related interstitial lung disease.

Journal: Journal of translational autoimmunity

Published: August 29, 2022

Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity.

Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity.

Journal: Frontiers in medicine

Published: November 01, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026